BOZEN, Italy, February 11 Health Robotics today announcedthe successful completion of the transition from its prior sales and supportchannels in North America to McKesson and Health Robotics Canada Inc., withtriple digit growth in sales and installations, renewal of North Americancustomers' commitment to Health Robotics' world-leading and revolutionaryproducts, and greatly improved customer satisfaction.
"I'm very satisfied with our progress since last Summer - we decided toterminate for cause the prior underperforming and inept distribution andservice channels in North America - and also with the fact that we haveaccomplished so much more over the last 6 months than in the prior 3 yearscombined, stated Werner Rainer, Health Robotics' CEO.
The first area that Health Robotics and its 2 new North American partnersset to rectify in August 2009 was the service personnel hiring and training,the creation of a North American spare parts depot, and the organization of acustomer help desk, all lacking from prior distributors, in direct andmaterial breach of their service obligations. Since last Fall, we have turnedthe corner on installations as confirmed by the CytoCare implementation atthe University of Pennsylvania Hospital and the renewed commitment toCytoCare by the University of Colorado Hospital and other key academicmedical centers in America.
"I want to congratulate McKesson for the commitment they showed toservice and support by devoting more than 15 FTEs to multiple months of bothclassroom and field training, culminating on February 5th with the hand-overto McKesson of all CytoCare service and support activities in North America.McKesson devoted in only 6 months over 100 times more hours to installationand training than all our prior distributors combined in the prior 3 years,culminating with the results achieved at Brigham and Women's Hospital whichmay be witnessed at http://www.health-robotics.com/en/customers/ and thatwere showcased February 8th on ABC News-Boston Channel, an example of thehigh level of customer satisfaction once the prior distributors were fired,"continued Mr. Rainer.
The next area (after service) that Health Robotics and its 2 new NorthAmerican partners set to significantly improve was to expand businessdevelopment activities. Starting with the December 2009 ASHP Midyearsymposium in Las Vegas, our 2 new North American distributors have generatedenough new contractual relationships in only 2 months to permit at least 50new installations in 2010, over ten times more units in only 1 year than theprior 3 years combined installations of the now-terminated prior distributionchannels. With the rest of 2010 still ahead of us, this is an unbelievableachievement.
"Although we still have a lot of work ahead of us in North America,including the optimization of new partners for TPNstation & the I.V. Room ofthe Future, we have now demonstrated with results what we suspected in prioryears about the unprecedented ineptitude of our prior distribution channels,blaming everyone else for their own shortcomings in frivolous lawsuitsagainst third parties [none against Health Robotics], including legal threatsto their own American hospital customers. It made no sense to us in prioryears that while our products received worldwide accolades, North America'sfeedback was so different. It is very rewarding now to see how positively thesame American hospitals perceive our products after they no longer have todeal with our prior distributors. Later this month we will begin to announcethe complete list of our 2 new partners' 2010 installations of CytoCare,i.v.STATION, & i.v.SOFT", stated Mr. Rainer.
About Health Robotics:
Health Robotics is the undisputed global leading supplier oflife-critical intra-venous Medication Admixture robots, providing healthcarefacilities in 4 continents with robotics technology and software automationsolutions. Its world-leading solutions CytoCare(TM) [hazardous IVs],i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manualcompounding], TPNstation(TM) [totally-automated parenteral nutrition] haveand will greatly contribute to ease hospitals' growing pressures to improvepatient safety. Through the effective and efficient production of sterile,accurate, tamper-evident and ready-to-administer IVs, Health Robotics helpshospitals to eliminate life-threatening drug-exchange errors, to decreaseother medication mistakes and sterility risks, to work more efficiently, toincrease throughput, to reduce waste and controlled substances' diversion, tocontain costs, and to reduce the gap between rising patient volume/acuity andscarce nursing and pharmacy staff. For more information, please visithttp://www.health-robotics.comFor additional information, please contact: Health Robotics Gaspar G. DeViedma, Executive V.P., General Counsel, and Member of the Board of Directors Italy: +39-346-963-4934 USA: +1-609-980-7976 Canada: +1-289-470-1456 Malaysia: +60-321-848-223 [email protected]
SOURCE Health Robotics